COMP <GO>
CNA vs BRK-B // FREE CASH FLOW YIELD
CNA Financial Corporation (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: CNA 9
— BRK-B 5
▲ FREE CASH FLOW YIELD LEADER: CNA
LAST: $48.68 (-0.39%) • MKT CAP: $13.22B
fcf-yield
18.18%
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
fcf-yield
2.09%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNA VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNA | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.70% | 11.47% | +8.23 | CNA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.8x | 9.7x | -4.88 | CNA | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 18.18% | 2.09% | +16.09 | CNA | /fcf-yield <GO> |
| Operating Margin | 75.00% | 27.80% | +47.20 | CNA | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 22.30% | +45.70 | CNA | /net-margins <GO> |
| Revenue Growth (YoY) | -2.00% | 3.93% | -5.93 | BRK-B | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 7.92% | 0.00% | +7.92 | CNA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.57 | 2.85 | -2.28 | BRK-B | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | CNA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 3.55% | +3.05 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.3 | 66.8 | -9.51 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.92 | 0.61 | +0.31 | CNA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.6x | 24.3x | -14.74 | CNA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.22B | $1.16T | -$1.15T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNA REV | BRK-B REV | CNA GROSS % | BRK-B GROSS % | CNA FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.58B | $371.44B | 44.0% | — | $2.40B | $25.04B |
| FY 2024 | $1.61B | $371.43B | 44.0% | — | $2.48B | $11.62B |
| FY 2023 | $1.62B | $364.48B | 44.0% | — | $2.21B | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNA // BETA 0.92
BRK-B // BETA 0.61